Form 4 for TRLV Trulieve Cannabis Corp.
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-24 · accession 0001209191-22-013799 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-28 | 2022-02-24 | TRLV | D'Amico Alex | CFO | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
| D | 2022-02-28 | 2022-02-24 | TRLV | D'Amico Alex | CFO | A - Grant | $0.00 | +57.3K | 57.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2022-02-24 | A | A | 20,135 | $0.00 | 20,135 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-02-24 | A | A | 57,343 | $0.00 | 57,343 | D | $21.48 · — to 2029-02-24 | 57,343 Subordinate Voting Shares | (F2) The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2022, one-third vesting on December 1, 2023, and one-third vesting on December 1, 2024. |